The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence
The purpose of this Notice of Funding Opportunity (NOFO) is to develop and implement protocols and recruitment strategies to evaluate the performance (sensitivity and specificity) of HIV tests under development, and/or newly available HIV tests, for use in point-of-care settings in the United States using fresh (unprocessed) specimens such as whole blood and oral fluid. Test sensitivity early in infection, when the antibody response is developing, and during conditions that might affect the detection of an analyte (HIV RNA, antigenic protein or antibody), is of particular interest; for example, determining test sensitivity in patients taking medications for antiretroviral therapy (ART) or HIV pre-exposure prophylaxis (PrEP). Therefore, protocols should address strategies for recruitment of patients with early HIV infection before they initiate ART, patients with HIV infection using ART, and HIV negative patients taking PrEP.
Only one application per institution is allowed
- Duke Internal: Interested applicants should contact Paul Noe (email@example.com) as early as possible.
- Letter of Intent: Mar. 16, 2020
- Application: Apr. 14, 2020